BamSEC and AlphaSense Join Forces
Learn More

ReShape Lifesciences Inc.

NASDAQ: RSLS    
Share price (1/7/25): $4.70    
Market cap (1/7/25): $3.350 million

Articles of Incorporation Filter

EX-3.1
from 8-K 3 pages ​ Certificate of Sixth Amendment to the Restated Certificate of Incorporation of ReShape Lifesciences Inc. ​
12/34/56
EX-3.1
from 8-K 15 pages ReShape Lifesciences Inc., a Delaware Corporation Amended and Restated Bylaws as Adopted January 16, 2024
12/34/56
EX-3.1
from 8-K 3 pages Certificate of Fifth Amendment to the Restated Certificate of Incorporation of ReShape Lifesciences Inc. ​
12/34/56
EX-3.1
from 8-K 7 pages Terms of Preferred Stock
12/34/56
EX-3.3
from 8-K 11 pages Terms of Preferred Stock
12/34/56
EX-3.2
from 8-K 2 pages Certificate of Fourth Amendment to the Restated Certificate of Incorporation of Obalon Therapeutics, Inc
12/34/56
EX-3.1
from 8-K 2 pages Certificate of Third Amendment to the Restated Certificate of Incorporation of Obalon Therapeutics, Inc
12/34/56
EX-3.1
from 8-K 1 page Certificate of Second Amendment to the Restated Certificate of Incorporation of Obalon Therapeutics, Inc
12/34/56
EX-3.1
from 8-K 2 pages Certificate of Amendment to the Restated Certificate of Incorporation of Obalon Therapeutics, Inc
12/34/56
EX-3.4
from S-1/A 20 pages Obalon Therapeutics, Inc., a Delaware Corporation Amended and Restated Bylaws as Adopted , 2016 Obalon Therapeutics, Inc., a Delaware Corporation Amended and Restated Bylaws
12/34/56
EX-3.2
from S-1/A 6 pages Restated Certificate of Incorporation of Obalon Therapeutics, Inc
12/34/56
EX-3.1
from S-1/A 22 pages Seventh Amended and Restated Certificate of Incorporation of Obalon Therapeutics, Inc
12/34/56
EX-3.3
from S-1 18 pages Obalon Therapeutics, Inc. By-Laws
12/34/56
EX-3.1
from S-1 20 pages Seventh Amended and Restated Certificate of Incorporation of Obalon Therapeutics, Inc
12/34/56
EX-3
from DRS 18 pages Obalon Therapeutics, Inc. By-Laws
12/34/56
EX-3
from DRS 20 pages Seventh Amended and Restated Certificate of Incorporation of Obalon Therapeutics, Inc
12/34/56